MD Anderson Research Highlights for January 11, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include promising results for neoadjuvant immunotherapy in solid tumors with certain DNA repair defects, new therapeutic targets for treatment-resistant EGFR-mutant lung cancer, a deeper look at prognostic elements for core binding factor...
